GLP-3 10mg
LOT MOL-102
95.40%
HPLC purity · meets spec
- Labeled
- 10mg
- Measured
- 10.79mg
- Identity
- Confirmed
- Tested
- Aug 7, 2026
3 assays passed · ISO/IEC 17025 accredited
View certificate
GLP-3 | Peptide Vials
10mg
$55.00
Regular price
$82.50
Sale price
$55.00
Skip to product information
GLP-3 | Peptide Vials
$55.00
Regular price
$82.50
Sale price
$55.00
Type
Bundle & save
Price
$55.00
For research use only. Not for human consumption. Compassionate curators of fine peptides.
GLP-3 · 10mg
Mollecule GLP-3 represents the next generation of precision peptide research. Comparable to the active ingredient in Retatrutide. As one of the newest compounds attracting attention within metabolic science, GLP-3 has become an important focus of ongoing scientific investigation. Every vial is produced with uncompromising quality standards and validated through independent third-party laboratory testing for purity and identity. Each batch includes a Certificate of Analysis (COA), reflecting the Mollecule commitment to transparency and research-grade excellence.
Pack
5mg Peptide Vials: $36.00
10mg Peptide Vials: $55.00
20mg Peptide Vials: $90.00
30mg Peptide Vials: $122.00
Also available: GLP-3 | 5ct Peptide Strips
Related peptides
Third-party verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch’s certificate below.
Sources & References
Peer-reviewed research
-
NEW ENGLAND JOURNAL OF MEDICINE
Triple-Hormone-Receptor Agonist GLP-3 (RT) for Obesity - A Phase 2 Trial
View Source -
THE LANCET
GLP-3 (RT) for People with Type 2 Diabetes - A Phase 2 Trial
View Source -
NATURE MEDICINE
GLP-3 (RT) for Metabolic Dysfunction-Associated Steatotic Liver Disease
View Source -
LANCET DIABETES & ENDOCRINOLOGY
Effects of GLP-3 (RT) on Body Composition
View Source -
PUBMED CENTRAL
Triple Agonism Based Therapies for Obesity
View Source -
PUBMED CENTRAL
GLP-3 (RT) - A Game Changer in Obesity Pharmacotherapy
View Source -
PUBMED CENTRAL
Efficacy and Safety of GLP-3 (RT) - Systematic Review & Meta-Analysis
View Source -
ELI LILLY
TRIUMPH-4 Phase 3 Trial Results
View Source -
NATURE CELL DISCOVERY
Structural Analysis of Incretin Receptor Agonists
View Source -
PUBCHEM DATABASE
GLP-3 (RT) Compound Information
View Source -
CLINICALTRIALS.GOV
GLP-3 (RT) Clinical Trials Registry
View Source